Company profile: Nightstar Therapeutics
1.1 - Company Overview
Company description
- Provider of biopharmaceutical gene therapy research and development focused on retinal dystrophies, aiming to enable treatments for rare conditions caused by single-gene mutations; U.K. startup.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Nightstar Therapeutics
Blue Heron Biotechnology
HQ: United States
Website
- Description: Provider of synthetic DNA sequences and related services for researchers and biotechnology companies, including custom gene synthesis (high GC, perfect repeats, hairpins, >20 kb), linear double-stranded gene fragments for cloning, CRISPR, and antibody engineering, plasmid preparation (standard/transfection grade, endotoxin-free), IVT mRNA for therapeutics, vaccine development, gene editing, expression studies, oligonucleotides, and Sanger/whole plasmid sequencing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Blue Heron Biotechnology company profile →
Gnubio
HQ: United States
Website
- Description: Provider of scalable desktop DNA sequencing systems for diagnostic and applied markets, integrating target selection, DNA amplification, sequencing, and analysis via emulsion-based droplet microfluidics. Offers single-use consumable cartridges and workflows for targeted sequencing and hotspot analysis, with whole genome and transcriptome applications in development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gnubio company profile →
Constellation Pharmaceuticals
HQ: United States
Website
- Description: Provider of novel therapeutics in the emerging field of epigenetics, focusing on selective regulators of epigenetic function critical to controlling gene expression; the first biopharmaceutical company dedicated to this area.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Constellation Pharmaceuticals company profile →
Frugi Bio
HQ: United States
Website
- Description: Provider of modular, paper-based, secure diagnostics for viral outbreak management using synthetic biology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Frugi Bio company profile →
Microsynbiotix
HQ: Ireland
Website
- Description: Provider of technology to eliminate excessive antibiotic use in farmed fish by engineering microalgae, leveraging advances in algal genomics and molecular biology to express inexpensive therapeutic proteins and vaccines of economic value.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Microsynbiotix company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Nightstar Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Nightstar Therapeutics
2.2 - Growth funds investing in similar companies to Nightstar Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Nightstar Therapeutics
4.2 - Public trading comparable groups for Nightstar Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →